| Typicality: | 0.243 |
| Saliency: | 0.190 |
| for rheumatoid arthritis | 3 | purpose |
| medicine → be approved in → the united states | 5 |
| medicine → be approved in → the u.s. | 4 |
| negative | neutral | positive |
| 0.048 | 0.455 | 0.496 |
| Raw frequency | 9 |
| Normalized frequency | 0.190 |
| Modifier score | 0.500 |
| Perplexity | 38.617 |